REGISTER
OCC 2026 | Precision Care for Heart Failure
The discussion explores the shift from empirical heart failure care to precision phenotyping. Prof. Chun Liang and Dr. Nazha Hamdani explain why “one-size-fits-all” treatment is no longer enough, and how deeper understanding of phenotypes and molecular mechanisms may support more targeted therapies.

In OCC 2026 Quest for Truth roundtable, leading cardiovascular experts gather to discuss “Heart Failure · Rebirth: Making the Broken Heart Beat Again”. The session is hosted by Prof. Gang Wu, Shanghai General Hospital, and co-moderated by Prof. Xuanxuan Li, Shi Jia Zhuang Great Wall Hospital. Quest for Truth is honored to welcome two distinguished interview guests: Dr. Nazha Hamdani, Ruhr-Universität Bochum; and Prof. Chun Liang, Shanghai Changzheng Hospital.

In this segment, the discussion begins with the shift from empirical care to precision phenotyping in heart failure. Prof. Gang Wu asks Prof. Chun Liang whether there was a pivotal clinical moment that made him realize heart failure treatment must move beyond a “one-size-fits-all” model and toward more individualized care.

Prof. Chun Liang explains that current heart failure care is largely guided by randomized clinical trials, including evidence for treatments such as beta-blockers and other standard therapies. However, he emphasizes that applying the same strategy to every patient is not ideal. Looking ahead, he hopes that stronger evidence will support more precise treatment for each heart failure patient.

Dr. Nazha Hamdani reflects on why her research moved deeply into basic science and molecular mechanisms. She notes that rising mortality in heart failure reflects the ongoing lack of effective therapies, making it necessary to understand the pathophysiology behind the disease. She emphasizes that heart failure is not a single condition, but a spectrum of phenotypes and subgroups, and that truly targeted therapies require a deeper understanding of basic and molecular mechanisms before returning to clinical application.

0
0
Loading